Interestingly, MYLS22 increased and decreased the proportion of G0 (Ki67-/DAPI-) and G1 (Ki67+/DAPI-) PDX AML cells ex vivo, respectively (Fig. 5E). Here, MKI67 is linked to acute myeloid leukemia.